EFFECTS OF DEXAMETHASONE ON MACROPHAGE MIGRATION INHIBITORY FACTOR PRODUCTION IN SEPSIS

ABSTRACT Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays a major role in the pathogenesis of sepsis. Some studies have indicated that glucocorticoids increase MIF production in physiological conditions. The goal of this study was to determine whether glucocorticoid treatment also upregulates MIF production in sepsis. Male NMRI mice (6-10 weeks old) underwent laparotomy, proximal ligation of the cecum, and double perforation with a 19-gauge needle (cecal ligation and puncture). Mice were randomly treated with saline (control) or dexamethasone at doses of 0.1, 1, or 10 mg/kg ip. At 6 or 18 h postoperatively, 10 mice per group were euthanized; and blood, peritoneal fluid, liver, lung, kidney, and heart tissue samples were retrieved. MIF, IL-6, TNF-&agr;, and IL-10 were measured by enzyme-linked immunosorbent assay. Sepsis induced by cecal ligation and puncture produced a marked increase in MIF and cytokine levels in plasma and peritoneal fluid. Treatment with dexamethasone 10 mg/kg decreased MIF levels in plasma after 18 h, but there was no effect of dexamethasone on MIF production locally in the peritoneal cavity or in the liver, lungs, heart, or kidneys. We conclude that glucocorticoid treatment does not upregulate MIF production in sepsis.

[1]  C. Metz,et al.  MACROPHAGE MIGRATION INHIBITORY FACTOR WITHIN THE ALVEOLAR SPACES INDUCES CHANGES IN THE HEART DURING LATE EXPERIMENTAL SEPSIS , 2005, Shock.

[2]  L. Leng,et al.  Macrophage migration inhibitory factor is released from pituitary folliculo-stellate-like cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition of interleukin 6 release. , 2004, Endocrinology.

[3]  D. Ray,et al.  Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. , 2004, Journal of molecular endocrinology.

[4]  D. Annane,et al.  Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. , 2005, The Journal of infectious diseases.

[5]  F. Bozza,et al.  CIRCULATING LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR ARE ASSOCIATED WITH MILD PULMONARY DYSFUNCTION AFTER CARDIOPULMONARY BYPASS , 2004, Shock.

[6]  F. Bozza,et al.  MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSIS , 2004, Shock.

[7]  M. Kitajima,et al.  Effects of Preinjury Administration of Corticosteroids on Pseudointimal Hyperplasia and Cytokine Response in a Rat Model of Balloon Aortic Injury , 2004, World Journal of Surgery.

[8]  P. Ward,et al.  Regulatory Role of C5a on Macrophage Migration Inhibitory Factor Release from Neutrophils1 , 2004, The Journal of Immunology.

[9]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[10]  F. Dhabhar,et al.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. , 2003, The American journal of pathology.

[11]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.

[12]  N. Petrovsky,et al.  Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  G. Fingerle-Rowson,et al.  Neuroendocrine properties of macrophage migration inhibitory factor (MIF) , 2001, Immunology and cell biology.

[14]  P. Ward,et al.  Role of C5a in Multiorgan Failure During Sepsis1 , 2001, The Journal of Immunology.

[15]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[16]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[17]  R. Bucala,et al.  Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. , 1999, Arthritis and rheumatism.

[18]  A. Satoskar,et al.  Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.

[19]  R. Atkins,et al.  Migration inhibitory factor expression in experimentally induced endotoxemia. , 1997, The American journal of pathology.

[20]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[21]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[22]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[23]  A. Chang,et al.  Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. , 1985, Circulatory shock.